Construction of a combined prognostic model for pancreatic ductal adenocarcinoma based on deep learning and digital pathology images
BMC Gastroenterology · 2024
DOI: 10.1186/s12876-024-03469-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Gastroenterology, 2024. Verfasst von Kaixin Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiaxing University Master Degree Cultivation Base, Zhejiang Chinese Medical University, Jiaxing, Zhejiang, China. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Deep Learning, Pancreatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Deep learning has made significant advancements in the field of digital pathology, and the integration of multiple models has further improved accuracy. In this study, we aimed to construct a combined prognostic model using deep learning-extracted features from digital pathology images of pancreatic ductal adenocarcinoma (PDAC) alongside clinical predictive indicators and to explore its prognostic value. METHODS: A retrospective analysis was conducted on 142 postoperative pathologically confirmed PDAC cases. These cases were divided into training (n = 114) and testing sets (n = 28) at an 8:2 ratio. Tumor whole-slide imaging features were extracted and screened to construct a pathological risk model based on a pre-trained deep learning model. Clinical and pathological data from the training set were used to select independent predictive factors for PDAC and establish a clinical risk model using LASSO, univariate, and multivariate Cox regression analyses. Based on the pathological and clinical risk models, a combined model was developed. The Harrell concordance index (C-index) was computed to assess the predictive performance of each model for PDAC survival prognosis. RESULTS: For the training and testing sets, the C-index values for the clinical risk model were 0.76 and 0.75, respectively; for the pathological risk model, they were 0.82 and 0.73, respectively; and for the combined model, they were 0.86 and 0.77, respectively. The combined model exhibited appropriate calibration at 1-, 3-, and 5-year time points, as well as a superior area under the curve of the receiver operating characteristic curve and clinical net benefit compared to the single models. CONCLUSIONS: Integrating the pathological and clinical risk models may provide a higher predictive value for survival prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jiaxing University Master Degree Cultivation Base, Zhejiang Chinese Medical University, Jiaxing, Zhejiang, China.
- Department of Hepatobiliary and Pancreatic Surgery, First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China.
- Jiaxing University Master Degree Cultivation Base, Zhejiang Chinese Medical University, Jiaxing, Zhejiang, China. lhb641834@163.com.
- Department of Hepatobiliary and Pancreatic Surgery, First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China. lhb641834@163.com.
Zitieren
APA
Hu, K., Bian, C., Yu, J., Jiang, D., Chen, Z., Zhao, F., & Li, H. (2024). Construction of a combined prognostic model for pancreatic ductal adenocarcinoma based on deep learning and digital pathology images. BMC Gastroenterology. https://doi.org/10.1186/s12876-024-03469-4
Vancouver
Hu K, Bian C, Yu J, Jiang D, Chen Z, Zhao F, et al. Construction of a combined prognostic model for pancreatic ductal adenocarcinoma based on deep learning and digital pathology images. BMC Gastroenterology. 2024. doi:10.1186/s12876-024-03469-4
BibTeX
@article{Hu2024,
author = {Hu, Kaixin and Bian, Chenyang and Yu, Jiayin and Jiang, Dawei and Chen, Zhangjun and Zhao, Fengqing and Li, Huangbao},
title = {Construction of a combined prognostic model for pancreatic ductal adenocarcinoma based on deep learning and digital pathology images},
journal = {BMC Gastroenterology},
year = {2024},
doi = {10.1186/s12876-024-03469-4}
}
EUVIMED